Israeli AI tech startup CytoReason raises $80M led by Nvidia and Pfizer to grow its AI drug discovery platform
CytoReason, an Israeli tech startup that uses AI to develop disease models, announced on Wednesday that it has secured $80 million in a private funding round to expand its AI drug discovery platform. The round was led by industry giants
The post Israeli AI tech startup CytoReason raises $80M led by Nvidia and Pfizer to grow its AI drug discovery platform first appeared on Tech Startups.
CytoReason, an Israeli tech startup that uses AI to develop disease models, announced on Wednesday that it has secured $80 million in a private funding round to expand its AI drug discovery platform. The round was led by industry giants […]
The post Israeli AI tech startup CytoReason raises $80M led by Nvidia and Pfizer to grow its AI drug discovery platform first appeared on Tech Startups.